1. Home
  2. CACI vs MDGL Comparison

CACI vs MDGL Comparison

Compare CACI & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$508.26

Market Cap

11.4B

Sector

Technology

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$521.36

Market Cap

12.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
MDGL
Founded
1962
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
12.1B
IPO Year
2007
2005

Fundamental Metrics

Financial Performance
Metric
CACI
MDGL
Price
$508.26
$521.36
Analyst Decision
Buy
Strong Buy
Analyst Count
13
12
Target Price
$673.45
$674.45
AVG Volume (30 Days)
270.3K
286.0K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
41.32
EPS
17.11
N/A
Revenue
$4,467,860,000.00
$180,133,000.00
Revenue This Year
$12.42
$58.39
Revenue Next Year
$10.00
$48.55
P/E Ratio
$29.44
N/A
Revenue Growth
2.60
N/A
52 Week Low
$409.62
$265.00
52 Week High
$683.50
$615.00

Technical Indicators

Market Signals
Indicator
CACI
MDGL
Relative Strength Index (RSI) 35.30 54.17
Support Level $499.81 $503.93
Resistance Level $537.69 $539.17
Average True Range (ATR) 21.17 16.01
MACD -1.45 -3.37
Stochastic Oscillator 21.20 42.85

Price Performance

Historical Comparison
CACI
MDGL

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: